ArticleJournal, genetic engineering & biotechnology2025
Cloning and expression of outer membrane proteins from Vibrio alginolyticus, and evaluation of their immune response in Epinephelus coioides.
Article in Journal, genetic engineering & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vibrio alginolyticus and Vibrio parahaemolyticus pose significant threats to various marine fish species, with mortality rates reaching as high as 90 %. Outer membrane proteins represent promising antigens for creating immune responses. The bacterial strains V. alginolyticus A2 and V. parahaemolyticus N9 were isolated from diseased grouper samples collected in Vietnam. The two bacterial strains, V. alginolyticus A2 and V. parahaemolyticus N9, were identified as highly virulent, causing disease in Epinephelus coioides. This study assesses the protective efficacy of the recombinant proteins OmpK and OmpU, derived from the ompK and ompU genes of V. alginolyticus A2, in E. coioides against the V. parahaemolyticus N9 and V. alginolyticus A2 strains. The ompK and ompU genes were 798 bp and 1023 bp in length, respectively, encoding polypeptide chains of 265 and 340 amino acids. The amino acid sequences of OmpK and OmpU proteins demonstrated high conservation across the other Vibrio species. The relative percent survival (RPS) for the OmpK protein in orange-spotted groupers challenged with V. alginolyticus A2 and V. parahaemolyticus N9 was 89.18 % and 72.22 %, respectively. Similarly, the group of fish injected with OmpU protein exhibited the RPS values of 82.14 % and 61.11 % against V. alginolyticus A2 and V. parahaemolyticus N9, respectively. Both recombinant antigenic proteins, OmpK and OmpU, induced a strong immune response in E. coioides to V. alginolyticus A2. Most interestingly, OmpK could also cross-protect against V. parahaemolyticus. This result suggests that OmpU and OmpK protein could be used as potential candidates for vaccine development targeting V. alginolyticus and V. parahaemolyticus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.